Company Overview

Originally founded as Sanarus Medical, Inc. in 1999, Sanarus Technologies, LLC is a medical device company committed to developing minimally invasive products for the comprehensive management of breast disease. Using proprietary cryoablation technology, Sanarus has demonstrated the ability to treat and destroy breast lesions, including benign and malignant tumors. 

With its innovative technology as the foundation, Sanarus has developed other complimentary and proprietary technologies to provide breast surgeons and radiologists with a comprehensive, minimally invasive set of devices to diagnose and treat their patients. 

Sanarus’ technology will fundamentally change the way patients receive treatment for breast tumors; from an operating room-based, surgical procedure using general anesthesia with longer recovery times to a quicker, more comfortable, cost-effective, office-based care pathway using only local anesthetic. This shift mirrors trends throughout healthcare to meet the demands of both payers and patients for minimally invasive solutions.